Respiratory Syncytial Virus among People Living with HIV: Is There a Case for Rolling Out Prophylaxis? A Viewpoint Based on a Systematic Review
Pathogens · 16.09.2024 · 13 (9) · 802
DOI: 10.3390/pathogens13090802 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pathogens, online erschienen am 16.09.2024. Verfasst von André Almeida und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine 4, Unidade Local de Saúde São José, 1150-199 Lisbon, Portugal. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, HIV Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Respiratory Syncytial Virus (RSV) is responsible for a considerable burden of respiratory disease among children and older adults. Several prophylactic strategies have recently been introduced. We review the available evidence on the interplay between RSV infection and HIV, looking at the specific role of RSV prophylactic strategies in individuals affected by or exposed to HIV. We conducted a systematic review on the association between HIV infection and RSV incidence and severity. We searched in PubMed/MEDLINE for clinical epidemiological studies covering outcomes such as RSV-associated illness, severity, and mortality in individuals affected by or exposed to HIV. A total of 36 studies met the inclusion criteria and were included, the majority conducted in sub-Saharan Africa. There was no compelling evidence suggesting a higher incidence of RSV illness among HIV-infected people. A higher risk of severe disease was consistent among both HIV-positive and HIV-exposed but uninfected (HEU) children. Case fatality rates were also higher for these groups. Evidence on a differing risk among adults was scarce. HIV-positive pregnant women should be given priority for recently approved RSV vaccination, for protection of their newborns. HIV-infected and HEU infants should be considered risk groups for nirsevimab prophylaxis in their first year of life and possibly beyond.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine 4, Unidade Local de Saúde São José, 1150-199 Lisbon, Portugal.
- NOVA Medical School, 1169-056 Lisbon, Portugal.
- Department of Internal Medicine 2.5, Unidade Local de Saúde São José, 1150-199 Lisbon, Portugal.
- Department of Medical and Surgical Sciences, University of Bologna, 40126 Bologna, Italy.
- Neonatal Intensive Care Unit, IRCCS AOU Bologna, 40139 Bologna, Italy.
- Department of Public Health and Paediatrics, University of Turin, 10124 Turin, Italy.
ORCID-Profile: André Almeida, Raffaele Aliberti, Arianna Aceti, Matteo Boattini
Zitieren
APA
Almeida, A., Aliberti, R., Aceti, A., & Boattini, M. (2024). Respiratory Syncytial Virus among People Living with HIV: Is There a Case for Rolling Out Prophylaxis? A Viewpoint Based on a Systematic Review. Pathogens, 13(9), 802. https://doi.org/10.3390/pathogens13090802
Vancouver
Almeida A, Aliberti R, Aceti A, Boattini M. Respiratory Syncytial Virus among People Living with HIV: Is There a Case for Rolling Out Prophylaxis? A Viewpoint Based on a Systematic Review. Pathogens. 2024;13(9):802. doi:10.3390/pathogens13090802
BibTeX
@article{Almeida2024,
author = {Almeida, André and Aliberti, Raffaele and Aceti, Arianna and Boattini, Matteo},
title = {Respiratory Syncytial Virus among People Living with HIV: Is There a Case for Rolling Out Prophylaxis? A Viewpoint Based on a Systematic Review},
journal = {Pathogens},
year = {2024},
volume = {13},
number = {9},
pages = {802},
doi = {10.3390/pathogens13090802}
}
EUVIMED